Quarterly report pursuant to Section 13 or 15(d)

Financial Instruments (Details)

v2.4.0.8
Financial Instruments (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Dec. 31, 2013
Jun. 30, 2013
Contract
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Mar. 31, 2013
Jul. 12, 2012
Dec. 31, 2013
Nano Vibronix [Member]
Dec. 31, 2013
Nano Vibronix [Member]
Dec. 31, 2013
Nano Vibronix [Member]
Convertible Promissory Note [Member]
Nov. 22, 2011
Nano Vibronix [Member]
Convertible Promissory Note [Member]
Dec. 31, 2013
Liability Warrants Having Exercise Price 30 [Member]
Financial Instruments [Abstract]                        
Foreign currency transaction gains and (losses) $ 0   $ 0 $ 0 $ 0              
Number of open foreign exchange contracts   0                    
Class of Warrant or Right [Line Items]                        
Exercise price of warrants outstanding (in dollars per share)                       $ 30.00
Non cash gains on warrants       10 3              
Note receivable - CollabRx 0     0                
Debt extinguishment as a consideration of acquisition   300                    
Promissory note liability assumed as a purchase price of acquisition   500         500          
Investment [Line Items]                        
Strategic investment 370     370   0 [1]         300  
Interest rate on convertible promissory note (in hundredths)                   10.00%    
Maturity date of convertible promissory note               Nov. 15, 2014 Nov. 15, 2014      
Convertible preferred stock               $ 3,000 $ 3,000      
Conversion price (in dollars per share)               $ 0.284 $ 0.284      
[1] Derived from the Company's audited consolidated financial statements.